Gelteq Limited
GELS
Last
$0.52
Day
-4.4%
1y
-59.6%
5y
-81.3%
52w
-72.7%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
0.57
EMA 50
0.60
EMA 200
0.76
20d high
-42.0%
5y high
-90.0%
5y range
3th
Positions held
Your positionsGELS isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-28
Hold
avoid
Signal
Strong Sell
Target
$0.69
Stop
$0.43
Stop distance
17.5%
Target vs last
+32.4%
Fundamentals
| Market cap | $5.88M | Enterprise value | $11.24M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 0.60 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 48.9% | Earnings growth | — | Gross margin | 75.5% | Operating margin | -19.9% |
| Profit margin | 0.0% | ROE | -42.9% | ROA | -17.6% | Debt / equity | 0.36 |
| Current ratio | 0.09 | Free cash flow | -$4.75M | Analyst recommendation | none | Mean target | — |
| 52w high | $2.01 | 52w low | $0.39 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $0.2M | $0.0M | $0.1M | $0.1M |
| Op margin | -2989.0% | — | -4232.9% | -2165.1% |
| Net income | -$6.6M | -$3.5M | -$3.5M | -$3.4M |
| Gross margin | — | — | 38.7% | 35.7% |
| Gross profit | — | $0.0M | $0.0M | $0.1M |
| Operating income | -$5.0M | -$2.6M | -$3.4M | -$3.2M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Could Gelteq’s (GELS) Gel Improve Oral Drug Delivery?
2026-09-03 · BC-Most Active Stocks
2026-09-02 · BC-Most Active Stocks
Price (daily)
Full chart · RSI · MACD · patternsGELS · daily-10.0% over 13 sessions
Close EMA21 EMA50 EMA200